Baoqing granules
Baoqing granules has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Apr 15, 2026: “The efficacy and safety of Femoston combined with Baoqing granules for kidney Yin deficiency in perimenopausal women: a randomized, double-blind, placebo-controlled trial”.
1 paper studies it2 findingsUpdated
See all 1 papers on baoqing granules
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“participants in the BQG group experienced greater short-term improvements that persisted at week 8 in Modified KMI, TCM syndrome scores, MENQOL, and PSQI”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave baoqing granules to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves Modified Kupperman Menopausal Index no change: Has no effect on blood lipids | Randomized trial4 weeks treatment plus 4 weeks follow-up | WomenMidlife adults; as an adjunct to Femoston | Frontiers in endocrinology, Apr 15, 2026 |
What did studies of baoqing granules find?
2Studies of baoqing granules measured 2 outcomes; the most studied are blood lipids (1 study) and Modified Kupperman Menopausal Index (1).
Blood lipids
no changein humans1
1 study
Blood lipids
no changein humans1
Baoqing granules showed no clear effect on blood lipids in humans (as an adjunct to Femoston).
“Hormone and lipid profiles showed no overall between-group differences”
Human trialas an adjunct to Femoston4 weeks treatment plus 4 weeks follow-upfemales
Frontiers in endocrinology
Modified Kupperman Menopausal Index
upin humans1
1 study
Modified Kupperman Menopausal Index
upin humans1
Baoqing granules improve Modified Kupperman Menopausal Index in humans (as an adjunct to Femoston).
“participants in the BQG group experienced greater short-term improvements that persisted at week 8 in Modified KMI, TCM syndrome scores, MENQOL, and PSQI”
Human trialas an adjunct to Femoston4 weeks treatment plus 4 weeks follow-upfemales
Frontiers in endocrinology